Sir HN Reliance Foundation Hospital sets up MR Fusion Biopsy machine
The MR Fusion Prostate biopsy equipment fuses MRI images with ultrasound equipment using AI to identify cancer areas with 90 per cent accuracy
With an aim to uplift cancer care in Maharashtra, Sir HN Reliance Foundation adds Maharashtra’s First MR Fusion Prostate Biopsy Equipment. The state-of-the-art MR Fusion Biopsy Equipment offers MRI blended biopsy creating a pathway for an accurate treatment and care. Compared to conventional machines with 30 per cent to 40 per cent accuracy, the MR Fusion biopsy equipment has 90 per cent accuracy is detecting prostate cancers at an early stage.
Dr Santoshi Janardan Nagaonkar, Director Urology, Urological Oncology & Robotic Surgery, Sir HN Reliance Foundation Hospital said, "The biopsy is performed using An MR Fusion equipment from a location known as the 'perineum,' which is positioned between the scrotum and anus, rather than the rectal route. As a result, instead of entering the prostate through the rectal lining, the biopsy needle must enter through the skin where the risk of infection following this biopsy is nearly zero."
He further added, “An MR Fusion prostate biopsy detects cancer at a greater rate than the standard approach. There is no risk of rectal bleeding, and it covers the entire prostate gland which is often inaccessible as part of the standard approach. There is no risk of damaging the rectum, therefore radical prostate ectomy can be performed within days."